Cargando…

Altered expression of genes controlling metabolism characterizes the tissue response to immune injury in lupus

To compare lupus pathogenesis in disparate tissues, we analyzed gene expression profiles of human discoid lupus erythematosus (DLE) and lupus nephritis (LN). We found common increases in myeloid cell-defining gene sets and decreases in genes controlling glucose and lipid metabolism in lupus-affected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kingsmore, Kathryn M., Bachali, Prathyusha, Catalina, Michelle D., Daamen, Andrea R., Heuer, Sarah E., Robl, Robert D., Grammer, Amrie C., Lipsky, Peter E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292402/ https://www.ncbi.nlm.nih.gov/pubmed/34285256 http://dx.doi.org/10.1038/s41598-021-93034-w

Ejemplares similares

Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients
por: Daamen, Andrea R., et al.
Publicado: (2023)

Analysis of gene expression from systemic lupus erythematosus synovium reveals myeloid cell-driven pathogenesis of lupus arthritis
por: Hubbard, Erika L., et al.
Publicado: (2020)

Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus
por: Labonte, Adam C., et al.
Publicado: (2018)

Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus
por: Catalina, Michelle D., et al.
Publicado: (2019)

Classification of COVID-19 Patients into Clinically Relevant Subsets by a Novel Machine Learning Pipeline Using Transcriptomic Features
por: Daamen, Andrea R., et al.
Publicado: (2023)

Analysis of transcriptomic features reveals molecular endotypes of SLE with clinical implications
por: Hubbard, Erika L., et al.
Publicado: (2023)

Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
por: Daamen, Andrea R., et al.
Publicado: (2021)

Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus
por: Catalina, Michelle D., et al.
Publicado: (2020)

Machine learning reveals distinct gene signature profiles in lesional and nonlesional regions of inflammatory skin diseases
por: Martínez, Brittany A., et al.
Publicado: (2022)

Nucleic Acid-Sensing and Interferon-Inducible Pathways Show Differential Methylation in MZ Twins Discordant for Lupus and Overexpression in Independent Lupus Samples: Implications for Pathogenic Mechanism and Drug Targeting
por: Marion, Miranda C., et al.
Publicado: (2021)

Machine learning approaches to predict lupus disease activity from gene expression data
por: Kegerreis, Brian, et al.
Publicado: (2019)

Differential regulation of the interferon response in systemic lupus erythematosus distinguishes patients of Asian ancestry
por: Rector, Ian, et al.
Publicado: (2023)

COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity
por: Daamen, Andrea R., et al.
Publicado: (2022)

An interpretable machine learning pipeline based on transcriptomics predicts phenotypes of lupus patients
por: Leventhal, Emily L., et al.
Publicado: (2023)

Abnormalities in intron retention characterize patients with systemic lupus erythematosus
por: Sun, Xiaoqian, et al.
Publicado: (2023)

B cell abnormalities in systemic lupus erythematosus
por: Grammer, Amrie C, et al.
Publicado: (2003)

Expression of Human Endogenous Retroviruses in Systemic Lupus Erythematosus: Multiomic Integration With Gene Expression
por: Stearrett, Nathaniel, et al.
Publicado: (2021)

Selective Histone Deacetylase 6 Inhibition Normalizes B Cell Activation and Germinal Center Formation in a Model of Systemic Lupus Erythematosus
por: Ren, Jingjing, et al.
Publicado: (2019)

Transcriptome and IgH Repertoire Analyses Show That CD11c(hi) B Cells Are a Distinct Population With Similarity to B Cells Arising in Autoimmunity and Infection
por: Maul, Robert W., et al.
Publicado: (2021)

Molecular Characterization of Circulating Plasma Cells in Patients with Active Systemic Lupus Erythematosus
por: Lugar, Patricia L., et al.
Publicado: (2012)

A comprehensive approach to identify approved drugs and treatments for repositioning as therapies for systemic lupus erythematosus
por: Grammer, Amrie C, et al.
Publicado: (2014)

Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry
por: Owen, Katherine A., et al.
Publicado: (2023)

Gut Microbiota and Bacterial DNA Suppress Autoimmunity by Stimulating Regulatory B Cells in a Murine Model of Lupus
por: Mu, Qinghui, et al.
Publicado: (2020)

The Impact of Protein Acetylation/Deacetylation on Systemic Lupus Erythematosus
por: Ren, Jingjing, et al.
Publicado: (2018)

Molecular endotypes of type 1 and type 2 SLE
por: Robl, Robert, et al.
Publicado: (2023)

Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases
por: Weißenberg, Sarah Y., et al.
Publicado: (2019)

Mendelian randomization and pathway analysis demonstrate shared genetic associations between lupus and coronary artery disease
por: Kain, Jessica, et al.
Publicado: (2022)

Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment
por: Wilson, John J., et al.
Publicado: (2023)

Hypovitaminosis A Drives the Progression of Tubulointerstitial Lupus Nephritis through Potentiating Predisease Cellular Autoreactivity
por: Abdelhamid, Leila, et al.
Publicado: (2023)

Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals
por: Grammer, Amrie C, et al.
Publicado: (2004)

Repertoire analysis of anergic B cells from patients with systemic lupus erythematosus
por: Longo, NS, et al.
Publicado: (2003)

Circulating anergic B cells in the periphery of active systemic lupus erythematosus patients: functional and phenotypic characterization
por: Grammer, A, et al.
Publicado: (2003)

Development of targeted biologics for systemic lupus erythematosus
por: Lipsky, Peter E
Publicado: (2012)

External Validation of the Lupus Multivariable Outcome Score for Systemic Lupus Erythematosus Trials
por: Abrahamowicz, Michal, et al.
Publicado: (2022)

Current Status of the Evaluation and Management of Lupus Patients and Future Prospects
por: Yavuz, Sule, et al.
Publicado: (2021)

Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2020)

Commentary: Systemic lupus erythematosus and cardiovascular disease: A Mendelian randomization study
por: Kerns, Sophia, et al.
Publicado: (2022)

Mechanisms of tissue injury in lupus nephritis
por: Nowling, Tamara K, et al.
Publicado: (2011)

Perturbations in the impact of mutational activity on Vλ genes in systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2001)

Expanded circulating transitional B cells in a patient with systemic lupus erythematosus
por: Ettinger, R, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_bngm03dcqbks0el2bng09a4qo2